FGF21, energy expenditure and weight loss - How much brown fat do you need?

Molecular Metabolism

Volumn 4, Issue 9, 2015, Pages 605-609

  Straub, Leon ^a   Wolfrum, Christian ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Brown fat; Energy expenditure; FGF21; UCP1

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; UNCOUPLING PROTEIN 1;

BROWN ADIPOSE TISSUE; DISEASE ASSOCIATION; DRUG MECHANISM; ENERGY EXPENDITURE; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC ACTIVATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; THERMOGENESIS; WEIGHT REDUCTION;

EID: 84940440284     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.06.008     Document Type: Review

References (59)

1. Prentice A.M. The emerging epidemic of obesity in developing countries. International Journal of Epidemiology 2006, 35(1):93-99. 10.1093/ije/dyi272.
2. Must A., Spadano J., Coakley E., Field A. The disease burden associated with overweight and obesity. JAMA 1999, 282(16):1523-1529.
3. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine 2003, 348(17):1625-1638.
4. Li M.-F., Cheung B.M. Rise and fall of anti-obesity drugs. World Journal of Diabetes 2011, 2(2):19-23. 10.4239/wjd.v2.i2.19.
5. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiological Reviews 2004, 84(1):277-359. 10.1152/physrev.00015.2003.
6. Bartelt A., Heeren J. Adipose tissue browning and metabolic health. Nature Reviews Endocrinology 2013, 10.1038/nrendo.2013.204.
7. Rosenwald M., Wolfrum C. The origin and definition of brite versus white and classical brown adipocytes. Adipocyte 2014, 3(1):4-9. 10.4161/adip.26232.
8. Rosenwald M., Perdikari A., Rülicke T., Wolfrum C. Bi-directional interconversion of brite and white adipocytes. Nature Cell Biology 2013, 15:1-11. 10.1038/ncb2740.
9. Wang Q., Tao C., Gupta R., Scherer P. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nature Medicine 2013, 5058:1-2.
10. Lee Y.-H., Petkova A.P., Konkar A.a, Granneman J.G. Cellular origins of cold-induced brown adipocytes in adult mice. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2015, 29(1):286-299. 10.1096/fj.14-263038.
11. Foster D.O., Frydman M.L. Tissue distribution of cold-induced thermogenesis in conscious warm- or cold-acclimated rats reevaluated from changes in tissue blood flow: the dominant role of brown adipose tissue in the replacement of shivering by nonshivering thermogenesis. Canadian Journal of Physiology and Pharmacology 1979, 57(3):257-270.
12. Heaton J.M. The distribution of brown adipose tissue in the human. Journal of Anatomy 1972, 112:35-39.
13. Lean M. Brown adipose tissue in humans. Proceedings of the Nutrition Society 1989, 48(2):243-257.
14. Van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J., Kemerink G.J., Bouvy N.D., et al. Cold-activated brown adipose tissue in healthy men. The New England Journal of Medicine 2009, 360(15):1500-1508. 10.1056/NEJMoa0808718.
15. Van Der Lans A.A.J.J., Hoeks J., Brans B., Vijgen G.H.E.J., Visser M.G.W., Vosselman M.J., et al. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. The Journal of Clinical Investigation 2013, 123(8):3395-3403.
16. Saito M., Okamatsu-ogura Y., Matsushita M., Watanabe K., Yoneshiro T., Nio-kobayashi J., et al. High incidence of metabolically active brown adipose tissue in healthy adult humans. Diabetes 2009, 58:1526-1531. 10.2337/db09-0530.
17. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., et al. Functional brown adipose tissue in healthy adults. The New England Journal of Medicine 2009, 360(15):1518-1525.
18. Cypess A., Lehman S., Williams G., Tal I., Rodman D., Goldfine A., et al. Identification and importance of brown adipose tissue in adult humans. The New England Journal of Medicine 2009, 360(15):1509-1517. 10.1056/NEJMoa0810780.
19. Yoneshiro T., Aita S., Mami M., Takashi K., Toshimitsu K., Yuko K., et al. Recruited brown adipose tissue as an antiobesity agent in humans. The Journal of Clinical Investigation 2013, 123(8):3404-3408. 10.1172/JCI67803DS1.
20. Cypess A.M., Weiner L.S., Roberts-Toler C., Elía E.F., Kessler S.H., Kahn P.A., et al. Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. Cell Metabolism 2015, 21(1):33-38. 10.1016/j.cmet.2014.12.009.
21. Kharitonenkov A. FGFs and metabolism. Current Opinion in Pharmacology 2009, 9(6):805-810. 10.1016/j.coph.2009.07.001.
22. Nishimura T., Nakatake Y., Konishi M., Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochimica et Biophysica Acta 2000, 1492:203-206.
23. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., et al. FGF-21 as a novel metabolic regulator. The Journal of Clinical Investigation 2005, 115(6):1627-1635. 10.1172/JCI23606.
24. Badman M.K., Koester A., Flier J.S., Kharitonenkov A., Maratos-Flier E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 2009, 150(11):4931-4940. 10.1210/en.2009-0532.
25. Xu J., Lloyd D.J., Hale C., Stanislaus S., Chen M., Sivits G., et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009, 58(1):250-259. 10.2337/db08-0392.
26. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nature Reviews Drug Discovery 2009, 8(3):235-253. 10.1038/nrd2792.
27. Liu J.-J., Foo J.P., Liu S., Lim S.C. The role of fibroblast growth factor 21 in diabetes and its complications: a review from clinical perspective. Diabetes Research and Clinical Practice 2015, 1-8. 10.1016/j.diabres.2015.02.032.
28. Yoneshiro T., Saito M. Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans. Annals of Medicine (March) 2014, 1-9. 10.3109/07853890.2014.911595.
29. Itoh N. FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases. Frontiers in Endocrinology 2014, 5(July):107. 10.3389/fendo.2014.00107.
30. Dushay J., Toschi E., Mitten E. Fructose ingestion acutely stimulates circulating FGF21 levels in humans. Molecular Metabolism 2015, 4:51-57. October 2014.
31. Hondares E., Rosell M., Gonzalez F.J., Giralt M., Iglesias R., Villarroya F. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metabolism 2010, 11(3):206-212. 10.1016/j.cmet.2010.02.001.
32. Hondares E., Iglesias R., Giralt A., Gonzalez F.J., Giralt M., Mampel T., et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. The Journal of Biological Chemistry 2011, 286(15):12983-12990. 10.1074/jbc.M110.215889.
33. Chartoumpekis D.V., Habeos I.G., Ziros P.G., Psyrogiannis A.I., Kyriazopoulou V.E., Papavassiliou A.G. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Molecular Medicine (Cambridge, Mass.) 2011, 17(7-8):736-740. 10.2119/molmed.2011.00075.
34. Keipert S., Kutschke M., Lamp D., Brachthäuser L., Neff F., Meyer C.W., et al. Genetic disruption of uncoupling protein 1 (UCP1) in mice renders brown adipose tissue a significant source of FGF21 secretion. Molecular Metabolism 2015, 2-7. 10.1016/j.molmet.2015.04.006.
35. Samms R.J., Smith D.P., Cheng C.C., Antonellis P.P., Perfield J.W., Kharitonenkov A., et al. Discrete aspects of FGF21 in vivo pharmacology do not require UCP1. Cell Reports 2015, 1-9. 10.1016/j.celrep.2015.04.046.
36. Keipert S., Ost M., Johann K., Imber F., Jastroch M., van Schothorst E.M., et al. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. American Journal of Physiology, Endocrinology and Metabolism 2014, 306(5):E469-E482. 10.1152/ajpendo.00330.2013.
37. Yang C., Jin C., Li X., Wang F., McKeehan W.L., Luo Y. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. PloS One 2012, 7(3):e33870. 10.1371/journal.pone.0033870.
38. Ding X., Boney-Montoya J., Owen B.M., Bookout A.L., Coate K.C., Mangelsdorf D.J., et al. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metabolism 2012, 16(3):387-393. 10.1016/j.cmet.2012.08.002.
39. Shan T., Liu W., Kuang S. Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2013, 27(1):277-287. 10.1096/fj.12-211516.
40. Elmasri H., Karaaslan C., Teper Y., Ghelfi E., Weng M., Ince T.a, et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2009, 23(11):3865-3873. 10.1096/fj.09-134882.
41. Makowski L., Boord J., Maeda K. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Medicine 2001, 699-705.
42. Sarruf D.a, Thaler J.P., Morton G.J., German J., Fischer J.D., Ogimoto K., et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 2010, 59(7):1817-1824. 10.2337/db09-1878.
43. Owen B.M., Ding X., Morgan D.A., Coate K.C., Bookout A.L., Rahmouni K., et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metabolism 2014, 20(4):670-677. 10.1016/j.cmet.2014.07.012.
44. Fisher F.M., Kleiner S., Douris N., Fox E.C., Mepani R.J., Verdeguer F., et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes & Development 2012, 26(3):271-281. 10.1101/gad.177857.111.
45. Véniant M.M., Sivits G., Helmering J., Komorowski R., Lee J., Fan W., et al. Pharmacologic effects of FGF21 are independent of the "Browning" of white adipose tissue. Cell Metabolism 2015, 21(5):731-738. 10.1016/j.cmet.2015.04.019.
46. Feldmann H.M., Golozoubova V., Cannon B., Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metabolism 2009, 9(2):203-209. 10.1016/j.cmet.2008.12.014.
47. Kopecky J., Clarke G., Enerbäck S., Spiegelman B., Kozak L.P. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. The Journal of Clinical Investigation 1995, 96(6):2914-2923. 10.1172/JCI118363.
48. Klaus S., Rudolph B., Dohrmann C., Wehr R. Expression of uncoupling protein 1 in skeletal muscle decreases muscle energy efficiency and affects thermoregulation and substrate oxidation. Physiological Genomics 2005, 21(2):193-200. 10.1152/physiolgenomics.00299.2004.
49. Cannon B., Nedergaard J. Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice (and probably in humans). International Journal of Obesity 2010, 34(Suppl 1(S1)):S7-S16. 2005. 10.1038/ijo.2010.177.
50. Liu X., Rossmeisl M. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. Journal of Clinical Investigation 2003, 111(3). 10.1172/JCI200315737.Introduction.
51. Okamatsu-Ogura Y., Kitao N., Kimura K., Saito M. Brown fat UCP1 is not involved in the febrile and thermogenic responses to IL-1beta in mice. American Journal of Physiology, Endocrinology and Metabolism 2007, 292(4):E1135-E1139. 10.1152/ajpendo.00425.2006.
52. Lowell B.B., Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
53. Granneman J.G., Burnazi M., Zhu Z., Schwamb L.A. White adipose tissue contributes to UCP1-independent thermogenesis. American Journal of Physiology, Endocrinology and Metabolism 2003, 285(6):E1230-E1236. 10.1152/ajpendo.00197.2003.
54. Ukropec J., Anunciado R.P., Ravussin Y., Hulver M.W., Kozak L.P. UCP1-independent thermogenesis in white adipose tissue of cold-acclimated Ucp1-/- mice. Journal of Biological Chemistry 2006, 281(42):31894-31908. 10.1074/jbc.M606114200.
55. Bal N.C., Maurya S.K., Sopariwala D.H., Sahoo S.K., Gupta S.C., Shaikh S.a, et al. Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. Nature Medicine 2012, 18(10):1575-1579. 10.1038/nm.2897.
56. She P., Reid T.M., Bronson S.K., Vary T.C., Hajnal A., Lynch C.J., et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metabolism 2007, 6(3):181-194. 10.1016/j.cmet.2007.08.003.
57. Mottillo E.P., Balasubramanian P., Lee Y.-H., Weng C., Kershaw E.E., Granneman J.G. Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation. Journal of Lipid Research 2014, 1-33. 10.1194/jlr.M050005.
58. Kiskinis E., Chatzeli L., Curry E., Kaforou M., Frontini A., Cinti S., et al. RIP140 represses the "brown-in-white" adipocyte program including a futile cycle of triacyclglycerol breakdown and synthesis. Molecular Endocrinology 2014, (Baltimore, Md.) 28(May): me20131254. 10.1210/me.2013-1254.
59. Schulz T.J., Huang P., Huang T.L., Xue R., McDougall L.E., Townsend K.L., et al. Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat. Nature 2013, 10.1038/nature11943.